TTM
34.4%
YoY change
−3.72pp
Trough year (1995)
-874.1%
Peak year (2015)
62.8%
Latest annual
32.1%
FCF Margin history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: 32.1%
FCF Margin change chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: −3.72pp
FCF Margin history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | 32.1% | -3.72pp | ||
| 2024 | 35.8% | +8.47pp | ||
| 2023 | 27.4% | -3.22pp | ||
| 2022 | 30.6% | -8.99pp | ||
| 2021 | 39.6% | +9.12pp | ||
| 2020 | 30.5% | -6.61pp | ||
| 2019 | 37.1% | +3.27pp | ||
| 2018 | 33.8% | -9.53pp | ||
| 2017 | 43.3% | -10.32pp | ||
| 2016 | 53.6% | -9.18pp | ||
| 2015 | 62.8% | +13.56pp | ||
| 2014 | 49.3% | +23.24pp | ||
| 2013 | 26.0% | -2.82pp | ||
| 2012 | 28.8% | -12.98pp | ||
| 2011 | 41.8% | +6.95pp | ||
| 2010 | 34.9% | -5.78pp | ||
| 2009 | 40.6% | +2.63pp | ||
| 2008 | 38.0% | -1.86pp | ||
| 2007 | 39.9% | +3.10pp | ||
| 2006 | 36.8% | +4.35pp | ||
| 2005 | 32.4% | -2.05pp | ||
| 2004 | 34.5% | +11.89pp | ||
| 2003 | 22.6% | +10.41pp | ||
| 2002 | 12.2% | +77.75pp | ||
| 2001 | -65.6% | -38.06pp | ||
| 2000 | -27.5% | +16.91pp | ||
| 1999 | -44.4% | -3.21pp | ||
| 1998 | -41.2% | +10.39pp | ||
| 1997 | -51.6% | +8.85pp | ||
| 1996 | -60.5% | +813.60pp | ||
| 1995 | -874.1% | -235.30pp | ||
| 1994 | -638.8% | — | ||
| 1992 | -316.7% | -166.67pp | ||
| 1991 | -150.0% | +57.69pp | ||
| 1990 | -207.7% | — |
- 202532.1%-3.72pp
- 202435.8%+8.47pp
- 202327.4%-3.22pp
- 202230.6%-8.99pp
- 202139.6%+9.12pp
- 202030.5%-6.61pp
- 201937.1%+3.27pp
- 201833.8%-9.53pp
- 201743.3%-10.32pp
- 201653.6%-9.18pp
- 201562.8%+13.56pp
- 201449.3%+23.24pp
- 201326.0%-2.82pp
- 201228.8%-12.98pp
- 201141.8%+6.95pp
- 201034.9%-5.78pp
- 200940.6%+2.63pp
- 200838.0%-1.86pp
- 200739.9%+3.10pp
- 200636.8%+4.35pp
- 200532.4%-2.05pp
- 200434.5%+11.89pp
- 200322.6%+10.41pp
- 200212.2%+77.75pp
- 2001-65.6%-38.06pp
- 2000-27.5%+16.91pp
- 1999-44.4%-3.21pp
- 1998-41.2%+10.39pp
- 1997-51.6%+8.85pp
- 1996-60.5%+813.60pp
- 1995-874.1%-235.30pp
- 1994-638.8%—
- 1992-316.7%-166.67pp
- 1991-150.0%+57.69pp
- 1990-207.7%—
FCF Margin values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported free cash flow margin is 34.4%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Gilead Sciences (GILD) most recent annual free cash flow margin stands at 32.12% (2025) – contracted 3.7 percentage points year-over-year.
The record annual free cash flow margin stands at 62.82%, reached in 2015; the historical low of -874.07% was recorded in 1995.
Gilead Sciences FCF Margin by Year
Gilead Sciences FCF Margin 2025: 32.1%
Gilead Sciences free cash flow margin in 2025 was 32.12%, contracted 3.7 percentage points from 2024.
Gilead Sciences FCF Margin 2024: 35.8%
2024's free cash flow margin for Gilead Sciences came in at 35.84%, expanded 8.5 percentage points from 2023.
Gilead Sciences FCF Margin 2023: 27.4%
Gilead Sciences posted free cash flow margin of 27.37% in 2023, contracted 3.2 percentage points from 2022.
Gilead Sciences FCF Margin 2022: 30.6%
In 2022, Gilead Sciences reported free cash flow margin of 30.59%, contracted 9.0 percentage points from 2021.
Gilead Sciences FCF Margin 2021: 39.6%
Gilead Sciences free cash flow margin in 2021 was 39.57%.
See more financial history for Gilead Sciences (GILD).
Sector peers by FCF Margin
Healthcare peers of Gilead Sciences (GILD), ranked by their latest free cash flow margin
| 33.2% | |
| 23.1% | |
| 21.5% | |
| 18.8% | |
| 18.4% | |
| 15.1% | |
| 9.4% | |
| 4.4% |
- 33.2%
- 23.1%
- 21.5%
- 18.8%
- 15.1%
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation